Within the newest bid for medical trial transparency, a French authorities working group has really helpful a sweeping plan to publicize research knowledge and concern pointers for guaranteeing that outcomes are made obtainable on a widespread and well timed foundation.
Notably, the working group urged that medical trial outcomes needs to be revealed in a registry inside a yr after a research is accomplished. The French Nationwide Company for the Security of Medicines and Well being Merchandise was additionally inspired to concern reminders to corporations, universities, and others about posting outcomes. And trial sponsors needs to be urged to include posting obligations in medical analysis coaching.
In making its case, the working group famous the French Open Science Monitor, which tracks points regarding open entry to analysis, discovered that solely 57% of the outcomes of French medical trials have been made public in medical trial registries, comparable to Clinicaltrials.gov within the U.S. or the European Union’s registry, between 2012 and 2022.
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
